COMPANY

Innovative Bio Venture developing a new concept of cell therapy

Digital Catalog

Since 2018.
2018 History
SCI Paper & IP
78 R&D Excellence
Equipment
27 R&D Competitiveness

Entr®
(Ultrasound-directed permeation of Environmental transition-guided cellular reprogramming)

Cell reprogramming induction technology of a new paradigm using only ultrasound and environmental control factors

Digital Cell Reprogramming

Automation system for Entr-based cell reprogramming induction

Reprosome®
(A cocktail of reprogramming factors in the exosomes )

Customized exosome containing various cell reprogramming factors induced from human fibroblasts with Entr technology, a core technology of STEMON.

Pipeline

Development of treatments for various intractable diseases using customized Reprosomes induced based on Entr technology

R&D

Research and development
of treatments for
intractable diseases

  • Entr®

  • Digital Cell Reprogramming

  • Reprosome®

  • Pipeline

NEWS

STEMON is adding values
to mankind with the best technology.

Full View
News

From Seoul to the World: StemOn Enters L'Oréal’s BIG BANG Innovation Program

StemOn has been selected as a finalist in the research and innovation category of L'Oréal's open innovation program, "L'Oréal BIG BANG"through the "K-Startup X France Meetup Day" jointly hosted by the Ministry of SMEs and Startups and L'Oréal Korea.The company was chosen for the program in recognition of the innovativeness of its digital cell reprogramming technology-based personalized functional cosmetic ingredients.Through this program, StemOn is expected to receive various forms of support, including opportunities for technological collaboration with L'Oréal’s global brand team, as well as mentoring, consulting, marketing, and networking.In addition, the company plans to receive up to 200 million KRW in commercialization funding and a customized specialized program from the Ministry of SMEs and Startups.

2025.05.20
News

STEMON Unveils Innovative Exosome-Based Skin Regeneration Technology at Shanghai CBE 2025

STEMON participated in the 2025 China Beauty Expo (CBE 2025), held from May 12 to 14 in Shanghai, where it showcased its cutting-edge exosome-based skin regeneration technology. Unlike conventional skincare, STEMON’s approach leverages a scientific method that promotes regeneration at the cellular level, drawing strong interest from industry professionals. The company’s solution, particularly effective in skin recovery and anti-aging, received notable attention. STEMON aims to leverage this exhibition to strengthen its technological competitiveness and brand presence across China and the broader Asian market. Meanwhile, CEO Soonhak Kim successfully delivered a presentation on the company’s technology during the “Korea Pavilion New Product Launch – Beauty Day” event on May 13.

2025.05.20
News

STEMON Participates in DUBAI DERMA 2025, Showcases Exosome Technology for the Middle Eastern Market

STEMON participated in DUBAI DERMA 2025, held in Dubai, UAE, from April 14 to 16, 2025, where it unveiled its advanced exosome-based technologies and skin regeneration solutions. During the exhibition, STEMON introduced a range of skincare products featuring its exosome technology, known for its effectiveness in skin repair and anti-aging, drawing significant attention from professionals in the medical and aesthetic fields as well as from visitors. Through this exhibition, STEMON aims to expand its presence in the global beauty market, including the Middle East, and actively pursue new partnership opportunities with local distributors and specialized clinics.

2025.04.23
News

STEMON at COSME TECH TOKYO 2025!

STEMON participated in COSME TECH TOKYO 2025, held from January 15 to 17, 2025, in Tokyo, Japan, where it presented its latest exosome technology and innovative beauty and skincare products. At the event, STEMON introduced exosome technology designed to enhance skin health and regeneration, drawing significant interest from industry experts and visitors. The company also showcased a variety of new beauty and skincare products, receiving positive feedback for their innovation. Through this exhibition, STEMON aims to expand its presence in the Japanese market and explore new partnership opportunities globally.

2025.01.21

Exosome-based Medical Device for Animals

Download Brochure

Exosome for Research

Download Brochure

Exosome Ingredients & Ampules for Cosmetics

Download Brochure

All Product Catalog

Learn More

Close

Do not show this again today.